Increase of SCF plasma concentration during donepezil treatment of patients with early Alzheimer's disease

International Journal of Neuropsychopharmacology

Volumn 12, Issue 10, 2009, Pages 1319-1326

  Leyhe, Thomas ^a   Hoffmann, Nadine ^a   Stransky, Elke ^a   Laske, Christoph ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Donepezil; granulocyte colony stimulating factor; stem cell factor; stromal cell derived factor 1; vascular endothelial growth factor

Indexed keywords

DONEPEZIL; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; BIOLOGICAL MARKER; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE;

ADULT; ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; UPREGULATION; AGED; BLOOD; BRIEF PSYCHIATRIC RATING SCALE; COMPARATIVE STUDY; TIME; TREATMENT OUTCOME;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRIEF PSYCHIATRIC RATING SCALE; FEMALE; HUMANS; INDANS; MALE; PIPERIDINES; STEM CELL FACTOR; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954049661     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145709990216     Document Type: Article

References (50)

1. Anderson DM, Lyman SD, Baird A, Wignall JM, et al. (1990). Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63, 235-243.
2. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington DC: American Psychiatric Association.
3. Blasko I, Grubeck-Loebenstein B (2003). Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's Disease. Drugs & Aging 20, 101-113. (Pubitemid 36246292)
4. Boissan M, Feger F, Guillosson JJ, ArockM(2000). c-Kit and c-kit mutations in mastocytosis and other haematological diseases. Journal of Leukocyte Biology 67, 135-148.
5. Broudy VC (1997). Stem cell factor and hematopoiesis. Blood 90, 1345-1364. (Pubitemid 27355406)
6. Cao L, Jiao X, Zuzga DS, Liu Y, et al. (2004). VEGF links hippocampal activity with neurogenesis, learning and memory. Nature Genetics 36, 827-835. (Pubitemid 39014099)
7. Corti S, Locatelli F, Strazzer S, Salani S, et al. (2002). Modulated generation of neuronal cells from bone marrow by expansion and mobilization of circulating stem cells with in vivo cytokine treatment. Experimental Neurology 177, 443-452. (Pubitemid 35366133)
8. Croizat H, Nagel RL (1999). Circulating cytokines response and the level of erythropoiesis in sickle cell anemia. American Journal of Hematology 60, 105-115. (Pubitemid 29047429)
9. Dhandapani KM, Wade FM, Wakade C, Mahesh VB, Brann DW (2005). Neuroprotection by stem cell factor in rat cortical neurons involves AKT and NFKB. Journal of Neurochemistry 95, 9-19. (Pubitemid 41384421)
10. Erlandsson A, Larsson J, Forsberg-Nilsson K (2004). Stem cell factor is a chemoattractant and a survival factor for CNS stem cells. Experimental Cell Research 301, 201-210. (Pubitemid 39504973)
11. Folstein MF, Folstein SE, McHugh PR (1975). 'Mini-Mental-State'. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12, 189-198.
12. Gazitt Y (2002). Comparison between granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the mobilization of peripheral blood stem cells. Current Opinion in Hematology 9, 190-198. (Pubitemid 34275964)
13. Greenberg DA, Jin K (2005). From angiogenesis to neuropathology. Nature 438, 954-959. (Pubitemid 43093961)
14. Hirota S, Ito A, Morii E, Wanaka A, et al. (1992). Localization of mRNA for c-kit receptor and its ligand in the brain of adult rats : an analysis using in situ hybridization histochemistry. Brain Research. Molecular Brain Research 15, 47-54.
15. Huang EJ, Nocka KH, Buck J, Besmer P (1992). Differential expression and processing of two cell associated forms of the kit-ligand : KL-1 and KL-2. Molecular Biology of the Cell 3, 349-362. (Pubitemid 23095970)
16. Jin K, Galvan V, Xie L, Mao XO, et al. (2004a). Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. Proceedings of the National Academy of Sciences USA 101, 13363-13367. (Pubitemid 39209671)
17. Jin K, Mao XO, Sun Y, Xie L, Greenberg DA (2002). Stem cell factor stimulates neurogenesis in vitro and in vivo. Journal of Clinical Investigation 110, 311-319. (Pubitemid 34847963)
18. Jin K, Peel AL, Mao XO, Xie L, et al. (2004b). Increased hippocampal neurogenesis in Alzheimer's disease. Proceedings of the National Academy of Sciences USA 101, 343-347. (Pubitemid 38084252)
19. Kaneko N, Okano H, Sawamoto K (2006). Role of the cholinergic system in regulating survival of newborn neurons in the adult mouse dentate gyrus and olfactory bulb. Genes to Cells 11, 1145-1159. (Pubitemid 44426205)
20. Katafuchi T, Li AJ, Hirota S, Kitamura Y, Horo T (2000). Impairment of spatial learning and hippocampal synaptic potentiation in c-kit mutant rats. Learning & Memory 7, 383-392. (Pubitemid 32003245)
21. Kawada H, Takizawa S, Takanashi T, Morita Y, et al. (2006). Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 113, 701-710.
22. Komine-Kobayashi M, Zhang N, Liu M, Tanaka R, et al. (2006). Neuroprotective effect of recombinant humangranulocyte colony-stimulating factor in transient focal ischemia of mice. Journal of Cerebral Blood Flow & Metabolism 26, 402-413.
23. Kotani S, Yamauchi T, Teramoto T, Ogura H (2006). Pharmacological evidence of cholinergic involvement in adult hippocampal neurogenesis in rats. Neuroscience 142, 505-514. (Pubitemid 44415335)
24. Kotani S, Yamauchi T, Teramoto T, Ogura H (2008). Donepezil, an acetylcholinesterase inhibitor, enhances adult hippocampal neurogenesis. Chemico-Biological Interactions 175, 227-230.
25. Lapidot T, Dar A, Kollet O (2005). How do stem cells find their way home? Blood 106, 1901-1910. (Pubitemid 41291700)
26. Laske C, Stellos K, Eschweiler GW, Leyhe T, Gawaz M (2008a). Decreased CXCL12 (SDF-1) plasma levels in early Alzheimer's Disease: A contribution to a deficient hematopoietic brain support? Journal of Alzheimer's Disease 15, 83-95.
27. Laske C, Stellos K, Stransky E, Seizer P, et al. (2008b). Decreased plasma and cerebrospinal fluid levels of stem cell factor in patients with early Alzheimer's Disease Journal of Alzheimer's Disease 15, 451-460.
28. Laske C, Stellos K, Stransky E, Leyhe T, Gawaz M (2009). Decreased plasma levels of granulocyte-colony stimulating factor (G-CSF) in patients with early Alzheimer's disease. Journal of Alzheimer's Disease 17, 115-123.
29. Leyhe T, Stransky E, Eschweiler GW, Buchkremer G, Laske C (2008). Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease. European Archives of Psychiatry and Clinical Neuroscience 258, 124-128. (Pubitemid 351441932)
30. Lopez-Toledano MA, Shelanski ML (2007). Increased neurogenesis in young transgenic mice overexpressing human APP(Sw,Ind). Journal of Alzheimer's Disease 12, 229-240. (Pubitemid 350179250)
31. Mateo I, Llorca J, Infante J, Rodrguez-Rodrguez E, et al. (2007). Low serum VEGF levels are associated with Alzheimer's disease. Acta Neurologica Scandinavica 116, 56-58. (Pubitemid 46976267)
32. Manova K, Bachvarova RF, Huang EJ, Sanchez S, et al. (1992). c-kit receptor and ligand expression in postnatal development of the mouse cerebellum suggests a function for c-kit in inhibitory interneurons. Journal of Neuroscience 12, 4663-4676.
33. Matsui Y, Zsebo KM, Hogan BL (1990). Embryonic expression of a haematopoietic growth factor encoded by the Sl locus and the ligand for c-kit. Nature 347, 667-669. (Pubitemid 20356242)
34. McKhann G, Drachman D, Folstein M, Katzman R, et al. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
35. Morii E, Hirota S, Kim HM, Mikoshiba K, et al. (1992). Spatial expression of genes encoding c-kit receptors and their ligands in mouse cerebellum as revealed by in situ hybridisation. Brain Research Developmental Brain Research 65, 123-126.
36. Motro B, Wojtowicz JM, Bernstein A, van der Kooy D (1996). Steel mutant mice are deficient in hippocampal learning but not long-term potentiation. Proceedings of the National Academy of Sciences USA 93, 1808-1813. (Pubitemid 26079836)
37. Nordberg A (2006). Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease. Alzheimer Disease and Associated Disorders 20 (2 Suppl. 1), S12-8. (Pubitemid 44305904)
38. Pakaski M, Rakonczay Z, Kasa P (2001). Reversible and irreversible acetylcholinesterase inhibitors cause changes in neuronal amyloid precursor protein processing and protein kinase C level in vitro. Neurochemistry International 38, 219-226.
39. Robin AM, Zhang ZG, Wang L, Zhang RL, et al. (2006). Stromal cell-derived factor 1a mediates neural progenitor cell motility after focal cerebral ischemia. Journal of Cerebral Blood Flow & Metabolism 26, 125-134. (Pubitemid 41818076)
40. Schneider A, Kruu¨ger C, Steigleder T, Weber D, et al. (2005). The hematopoietic factor G-CSF is aneuronal ligand that counteract programmed cell death and drives neurogenesis. Journal of Clinical Investigation 115, 2083-2098. (Pubitemid 41134150)
41. Shetty AK, Hattiangady B, Shetty GA (2005). Stem/progenitor cell proliferation factors FGF-2, IGF-1, and VEGF exhibit early decline during the course of aging in the hippocampus : role of astrocytes. Glia 51, 173-186. (Pubitemid 41297424)
42. Stumm R, Hou¨llt V (2007). CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: implications for neuronal regeneration in the adult brain. Journal of Molecular Endocrinology 38, 377-382. (Pubitemid 46723253)
43. Sun L, Lee J, Fine HA (2004). Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. Journal of Clinical Investigation 113, 1364-1374. (Pubitemid 39069935)
44. WHO (1992). Tenth Revision of the International Classification of Diseases. Chapter 5 (F) : Mental and behavioural disorders (including disorders of psychological development). Clinical Descriptions and Diagnosic Guidelines. Geneva World Health Organization.
45. Winblad B, Jelic V (2004). Long-term treatment of Alzheimer disease : efficacy and safety of acetylcholinesterase inhibitors. Alzheimer Disease & Associated Disorders 18 (Suppl. 1), S2-S8. (Pubitemid 38737787)
46. Zhang SC, Fedoroff S (1998). Modulation of microglia by stem cell factor. Journal of Neuroscience Research 53, 29-37. (Pubitemid 28308979)
47. Zhang SC, Fedoroff S (1999). Expression of stem cell factor and c-kit receptor in neural cells after brain injury. Acta Neuropathologica 97, 393-398. (Pubitemid 29134520)
48. Zhao LR, Navalitloha Y, Singhal S, Mehta J, et al. (2007b). Hematopoietic growth factors pass through the blood-brain barrier in intact rats. Experimental Neurology 204, 569-573. (Pubitemid 46497044)
49. Zhao LR, Singhal S, Duan WM, Mehta J, Kessler JA (2007a). Brain repair by hematopoietic growth factors in a rat model of stroke. Stroke 38, 2584-2591. (Pubitemid 47329641)
50. Zhou B, Han ZC, Poon MC, Pu W (2007). Mesenchymalstem/stromal cells (MSC) transfected with stromal derivedfactor 1 (SDF-1) for therapeutic neovascularization : Enhancement of cell recruitment and entrapment. Medical Hypotheses 68, 1268-1271. (Pubitemid 46509696)